Regulatory/IP update

*Watson Receives FDA Approval of Potassium Chloride Extended-Release Capsules USP in the 8mEq and 10mEq strengths.

*Boca Pharmacal Receives FDA Approval for Carbinoxamine Maleate 4 mg Tablet

*Lannett Company to Launch Amantadine Hydrochloride Soft Gel Capsules, 100 mg

*Watson Receives Final Approval of Omeprazole Delayed-Release Capsules 10mg, 20mg and 40mg

*U.S. Patent & Trademark Office (PTO) has completed the second of four reexamination proceedings and has confirmed the patentability of US5922695 which covers the composition of matter for Viread (Tenofovir Disoproxil Fumarate).

*Barr has filed Paragraph IV on Entocort Enteric Coated Capsules (Budesonide), 3mg. The Company believes that it is the first to file an Abbreviated New Drug Application (ANDA) containing a paragraph IV certification for Entocort